Jonathan Douxfils to Thrombosis
This is a "connection" page, showing publications Jonathan Douxfils has written about Thrombosis.
Connection Strength
0.461
-
Hypotheses behind the very rare cases of thrombosis with thrombocytopenia syndrome after SARS-CoV-2 vaccination. Thromb Res. 2021 07; 203:163-171.
Score: 0.185
-
Optimal wavelength for the clot waveform analysis: Determination of the best resolution with minimal interference of the reagents. Int J Lab Hematol. 2019 Jun; 41(3):316-324.
Score: 0.158
-
Studies on hemostasis in COVID-19 deserve careful reporting of the laboratory methods, their significance, and their limitations. J Thromb Haemost. 2020 11; 18(11):3121-3124.
Score: 0.045
-
[Management of the thrombotic risk associated with COVID-19: what is the role of the hemostasis laboratory?] Ann Biol Clin (Paris). 2020 10 01; 78(5):471-481.
Score: 0.044
-
Anticoagulation With an Inhibitor of Factors XIa and XIIa During Cardiopulmonary Bypass. J Am Coll Cardiol. 2019 10 29; 74(17):2178-2189.
Score: 0.010
-
Prospective and comparative study of paroxysmal nocturnal hemoglobinuria patients treated or not by eculizumab: Focus on platelet extracellular vesicles. Medicine (Baltimore). 2019 Jul; 98(27):e16164.
Score: 0.010
-
Application of a clot-based assay to measure the procoagulant activity of stored allogeneic red blood cell concentrates. Blood Transfus. 2018 02; 16(2):163-172.
Score: 0.009